Total Funding
90
64
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
8802
Silexion Therapeutics is a biotechnology company that provides research and development for oncology treatments.
Amotz Shemi: Founder & CEO
About the Company
Silexion Therapeutics is a biotechnology company that focuses on developing treatments for KRAS-driven cancers. The company's lead product, SIL-204, is a small interfering RNA (siRNA) therapy in an extended-release formulation for the treatment of locally advanced pancreatic cancer. Silexion offers its clinical-stage oncology platform with
plans for further trials to improve treatment outcomes for patients with specific KRAS mutations.
